About the Research Trials

How will the trials be done?
A sample of each patient's breast cancer tumor tissue and blood will be analyzed using a combined approach of three new technologies, including: genomics, which allows investigators to examine the DNA of the breast cancer cell; proteomics, which performs a similar task with cancer cell proteins; and pharmacogenetics, the study of inherited differences in drug effects.

What will the trial results tell us?
By combining the predictive powers of genomics, proteomics and pharmacogenetics (link or window with definition/explanation of terms) with existing technology in bioinformatics and pathology will produce a recipe for individualized therapeutic treatment that can be tested in a clinical setting. The collected data will be analyzed to create a treatment algorithm for matching the right drug to the right woman, based on her genetic and protein makeup and the specific type of breast cancer she has.

To view more information about the COE trials click on a trial below.
COE-C01 Information Sheet
COE-C02 Information Sheet (coming soon)
COE-C03 Information Sheet (coming soon)
COE-C04 Information Sheet (coming soon)